What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medication that mimics the action of a naturally occurring hormone involved in blood sugar regulation and appetite control. Originally developed for the management of type 2 diabetes, semaglutide was subsequently studied and approved at higher doses specifically for chronic weight management in adults with obesity or overweight conditions accompanied by at least one weight-related health concern.
GLP-1 is produced in the gut in response to food intake. It signals the pancreas to release insulin, slows gastric emptying so that food moves through the digestive system more gradually, and communicates with the brain's appetite-regulating centers to reduce hunger and increase feelings of fullness. Semaglutide amplifies these effects, helping patients consume less food without the constant struggle against hunger that characterizes most conventional diets.
How Semaglutide Supports Weight Loss
The clinical evidence supporting semaglutide for weight management is substantial. In large-scale trials, participants using semaglutide alongside lifestyle modifications achieved average weight reductions significantly greater than those seen with lifestyle changes alone. Many participants lost 15 percent or more of their body weight over the course of treatment.
Beyond the numbers on the scale, meaningful weight loss can improve blood pressure, blood sugar regulation, cholesterol levels, joint health, sleep quality, and overall energy. For women dealing with hormonal imbalances, PCOS, or the metabolic shifts of perimenopause and menopause, weight management can also support hormonal health and reduce the risk of related complications.
Semaglutide is administered as a once-weekly subcutaneous injection. Dosing typically begins at a low level and is gradually increased over several months to the target therapeutic dose, a process that helps minimize gastrointestinal side effects such as nausea, which are most common during the initial titration period.
Who Is a Candidate for Semaglutide?
Medical weight loss with semaglutide is not appropriate for everyone, and a thorough medical evaluation is essential before beginning treatment. Generally, candidates include adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol.
Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, or for those who are pregnant or planning to become pregnant. A complete review of medical history, current medications, and health goals is necessary to determine whether semaglutide is a safe and appropriate option.
What a Medical Weight Loss Program Looks Like
Semaglutide is most effective when used as part of a comprehensive medical weight loss program rather than as a standalone treatment. A well-designed program includes an initial medical evaluation and baseline testing, personalized dosing and ongoing monitoring for safety and effectiveness, nutritional guidance tailored to support the metabolic changes occurring during treatment, and regular follow-up appointments to track progress and address any concerns.
The goal is not simply to lose weight during the treatment period but to develop sustainable habits and address the underlying factors, whether hormonal, metabolic, or behavioral, that have contributed to weight challenges. For women whose weight is connected to hormonal imbalances, incorporating hormonal evaluation and treatment alongside medical weight loss can produce more comprehensive and lasting results.
Realistic Expectations and Long-Term Considerations
Semaglutide is a powerful tool, but it is not a permanent fix on its own. Weight regain can occur if the medication is discontinued without the lifestyle foundation to support maintenance. The most successful patients approach medical weight loss as a long-term commitment to health rather than a short-term intervention.
It is also worth noting that individual responses to semaglutide vary. Some patients experience rapid and dramatic results, while others see more gradual progress. Factors such as starting weight, metabolic health, hormonal status, diet quality, and activity level all influence outcomes.
Take the First Step Toward Sustainable Weight Loss
If you have struggled with weight management despite genuine effort, medical weight loss with semaglutide may offer the support your body needs to achieve meaningful and lasting results. You deserve a program that works with your biology, not against it.
Contact 3 Point Elite today at (301) 747-1635 to schedule a medical weight loss consultation in Silver Spring MD and find out whether semaglutide is right for you.
Disclaimer: The information provided in this article is for educational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional before starting any new treatment or wellness program. Semaglutide is a prescription medication and must be prescribed and monitored by a licensed healthcare provider.